Select Page

Pfizer Biontech Vaccine Agreement

On November 9, 2020, Pfizer and BioNTech announced that their COVID-19 vaccine candidate had shown a 90% efficacy rate in early-stage trials. This was exciting news in the fight against COVID-19, and since then, the two companies have been working to make...